This was the stock's third consecutive day of losses.

Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...

In a report released yesterday, Murray Connellan from MA Financial Group maintained a Buy rating on Dexus Convenience Retail REIT (DXC – Research Report), with a price target of A$3.39.

DXC Technology Co. closed 28.51% below its 52-week high of $24.83, which the company achieved on November 8th.